MeSH term
Frequency | Condition_Probility | Animals | 83 | 0.0 |
Aortic Aneurysm/surgery | 2 | 13.0 |
Bioprosthesis/standards | 2 | 15.0 |
Equipment Failure | 2 | 8.0 |
Heart Valve Diseases/pathology/surgery | 2 | 15.0 |
Heart Valve Prosthesis/*standards | 2 | 15.0 |
Humans | 127 | 0.0 |
Postoperative Complications/etiology | 2 | 5.0 |
Prosthesis Design | 2 | 4.0 |
*Stents | 2 | 3.0 |
Swine | 2 | 0.0 |
Base Sequence | 18 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
English Abstract | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 5 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
*Apolipoproteins | 2 | 6.0 |
Binding Sites | 18 | 0.0 |
Conserved Sequence | 2 | 0.0 |
DNA-Binding Proteins/drug effects/genetics/*metabolism | 2 | 14.0 |
Drug Synergism | 4 | 0.0 |
Female | 27 | 0.0 |
*Glycoproteins | 2 | 0.0 |
*Membrane Transport Proteins | 2 | 0.0 |
*Milk Proteins | 107 | 22.0 |
Molecular Sequence Data | 25 | 0.0 |
Mutation | 4 | 0.0 |
Promoter Regions (Genetics) | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 74 | 0.0 |
Response Elements | 4 | 1.0 |
Signal Transduction | 20 | 0.0 |
Trans-Activation (Genetics) | 9 | 0.0 |
Trans-Activators/drug effects/genetics/*metabolism | 2 | 16.0 |
Tumor Cells, Cultured | 27 | 0.0 |
Blotting, Western | 9 | 0.0 |
Growth Hormone/*pharmacology | 8 | 10.0 |
Phosphorylation | 47 | 0.0 |
Precipitin Tests | 13 | 0.0 |
Protein-Tyrosine Kinase/physiology | 3 | 2.0 |
*Proto-Oncogene Proteins | 24 | 1.0 |
Receptors, Somatotropin/genetics/physiology | 2 | 66.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 46 | 0.0 |
Signal Transduction/*drug effects | 9 | 2.0 |
Transfection | 24 | 0.0 |
Tyrosine/metabolism | 22 | 1.0 |
Antigens, CD/metabolism | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 26 | 1.0 |
Membrane Glycoproteins/metabolism | 3 | 0.0 |
Recombinant Proteins/metabolism/pharmacology | 3 | 2.0 |
Trans-Activators/*metabolism | 27 | 2.0 |
Cell Differentiation/drug effects | 3 | 0.0 |
Cell Nucleus/metabolism | 9 | 0.0 |
Cells, Cultured | 25 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 4 | 1.0 |
Prolactin/*metabolism | 3 | 5.0 |
Trans-Activators/genetics/*physiology | 4 | 4.0 |
Transcription, Genetic | 12 | 0.0 |
DNA-Binding Proteins/*genetics | 6 | 0.0 |
Exons | 2 | 0.0 |
Gene Expression | 8 | 0.0 |
Hela Cells | 4 | 0.0 |
Phylogeny | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Trans-Activators/*genetics | 6 | 1.0 |
DNA/metabolism | 10 | 0.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Hypophysectomy | 2 | 3.0 |
Immunoblotting | 4 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Mice | 45 | 0.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Mice, Knockout | 6 | 0.0 |
Pregnancy | 4 | 0.0 |
Prolactin/pharmacology | 3 | 8.0 |
Cell Division | 9 | 0.0 |
Cell Line, Transformed | 4 | 0.0 |
DNA-Binding Proteins/genetics/metabolism/*physiology | 2 | 3.0 |
Receptor, Epidermal Growth Factor/metabolism | 3 | 0.0 |
Trans-Activators/genetics/metabolism/*physiology | 2 | 7.0 |
Dimerization | 6 | 0.0 |
Drug Interactions | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Tretinoin/pharmacology | 2 | 0.0 |
Cell Line | 34 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Luciferases/metabolism | 4 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 9 | 0.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Time Factors | 3 | 0.0 |
Phosphoproteins/genetics | 2 | 1.0 |
Apoptosis/drug effects | 2 | 0.0 |
Cell Survival/drug effects | 2 | 0.0 |
Enzyme Activation | 10 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 13 | 1.0 |
Growth Hormone/*physiology | 2 | 7.0 |
Mice, Transgenic | 4 | 0.0 |
Aged | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 18 | 1.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Male | 23 | 0.0 |
Middle Aged | 6 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Trans-Activators/genetics/*metabolism | 16 | 4.0 |
Comparative Study | 6 | 0.0 |
DNA-Binding Proteins/metabolism | 10 | 0.0 |
Dose-Response Relationship, Drug | 7 | 0.0 |
Phosphorylation/drug effects | 3 | 0.0 |
Rats | 23 | 0.0 |
Rats, Inbred WF | 2 | 9.0 |
Trans-Activators/metabolism | 11 | 1.0 |
Amino Acid Sequence | 21 | 0.0 |
Mutagenesis, Site-Directed | 7 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Tyrosine/chemistry/metabolism | 2 | 11.0 |
3T3 Cells | 4 | 0.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
COS Cells | 13 | 0.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Plasmids/metabolism | 3 | 0.0 |
Protein Binding | 12 | 0.0 |
Receptors, Prolactin/metabolism | 2 | 12.0 |
*Signal Transduction | 14 | 0.0 |
Transcription Factors/metabolism | 6 | 0.0 |
Protein Isoforms | 4 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Signal Transduction/physiology | 5 | 0.0 |
Cell Division/drug effects | 6 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Hematopoietic Stem Cells/*cytology/drug effects | 3 | 4.0 |
*Neoplasm Proteins | 2 | 0.0 |
Signal Transduction/drug effects/*immunology | 2 | 5.0 |
Interferon Type II/metabolism | 2 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
*Repressor Proteins | 5 | 0.0 |
*Transcription Factors | 5 | 0.0 |
Genes, Reporter | 5 | 0.0 |
Liver/metabolism | 5 | 0.0 |
Amino Acid Motifs | 3 | 0.0 |
Interleukin-2/*pharmacology | 7 | 2.0 |
Receptors, Interleukin-2/*genetics | 3 | 11.0 |
*Receptors, Cell Surface | 2 | 0.0 |
Signal Transduction/*physiology | 8 | 0.0 |
Luciferases/genetics | 3 | 0.0 |
Mice, Inbred C3H | 2 | 0.0 |
Mutagenesis | 4 | 0.0 |
Plasmids/genetics | 2 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
*Transcription, Genetic/drug effects | 2 | 1.0 |
1-Phosphatidylinositol 3-Kinase/*physiology | 2 | 3.0 |
Enzyme Inhibitors/pharmacology | 5 | 0.0 |
Kinetics | 9 | 0.0 |
Proto-Oncogene Proteins/metabolism | 3 | 0.0 |
Tyrphostins/pharmacology | 4 | 2.0 |
Cell Division/physiology | 2 | 0.0 |
Cell Survival/physiology | 2 | 1.0 |
*Protein-Serine-Threonine Kinases | 4 | 0.0 |
Dogs | 2 | 0.0 |
DNA-Binding Proteins/*physiology | 9 | 1.0 |
Insulin/*pharmacology | 2 | 0.0 |
Trans-Activators/*physiology | 8 | 3.0 |
Adenoviridae/genetics | 2 | 0.0 |
Mice, Nude | 2 | 0.0 |
DNA-Binding Proteins/antagonists & inhibitors/metabolism | 2 | 9.0 |
Serine/metabolism | 5 | 1.0 |
Trans-Activators/antagonists & inhibitors/metabolism | 3 | 15.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Caspases/metabolism | 2 | 0.0 |
Cell Line, Tumor | 6 | 0.0 |
Protein-Tyrosine Kinase/genetics/metabolism | 3 | 4.0 |
Tyrosine/*metabolism | 4 | 1.0 |
DNA-Binding Proteins/chemistry/*metabolism | 4 | 2.0 |
Trans-Activators/chemistry/*metabolism | 4 | 6.0 |
Protein Binding/drug effects | 2 | 0.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Cell Division/drug effects/physiology | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/metabolism | 4 | 3.0 |
Proteins/metabolism | 2 | 0.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Human Growth Hormone/pharmacology | 2 | 11.0 |
Phosphotyrosine/metabolism | 8 | 1.0 |
src Homology Domains | 5 | 0.0 |
Apoptosis | 2 | 0.0 |
Gene Expression Regulation | 7 | 0.0 |
Growth Hormone/*metabolism | 4 | 7.0 |
Milk Proteins | 2 | 25.0 |
Models, Biological | 5 | 0.0 |
Protein Conformation | 3 | 0.0 |
*Sex Characteristics | 2 | 1.0 |
Trans-Activators/physiology | 2 | 1.0 |
Immune Tolerance | 2 | 0.0 |
Cattle | 3 | 0.0 |
DNA/genetics | 3 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Cytokines/metabolism | 2 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Thrombopoietin/*pharmacology | 2 | 2.0 |
Binding, Competitive | 2 | 0.0 |
Gene Expression/drug effects | 2 | 0.0 |
Insulin/pharmacology | 2 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 3 | 0.0 |
Rats, Inbred F344 | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Chromosomes, Human, Pair 17 | 3 | 0.0 |
Signal Transduction/genetics | 2 | 0.0 |
Translocation, Genetic | 2 | 0.0 |
Azepines/pharmacology | 2 | 9.0 |
Macromolecular Substances | 3 | 0.0 |
Triazoles/pharmacology | 2 | 6.0 |
Cell Differentiation | 3 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Mitogen-Activated Protein Kinase 1 | 2 | 1.0 |
*Mitogen-Activated Protein Kinases | 2 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Interleukin-2/*metabolism/pharmacology | 2 | 28.0 |
Rabbits | 2 | 0.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
*Gene Expression Regulation | 5 | 0.0 |
Prolactin/*physiology | 2 | 5.0 |
*Promoter Regions (Genetics) | 5 | 0.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
Interleukin-7/*pharmacology | 3 | 7.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 2 | 0.0 |
Erythropoietin/*pharmacology | 3 | 2.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
Receptors, Cytokine/*metabolism | 2 | 2.0 |
Interleukin-12/pharmacology | 2 | 4.0 |
Interleukin-15/pharmacology | 3 | 13.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Adult | 7 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology | 3 | 1.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
DNA/*metabolism | 3 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Phenotype | 2 | 0.0 |
*Point Mutation | 2 | 0.0 |
DNA-Binding Proteins/chemistry/*genetics/*metabolism | 2 | 5.0 |
Sequence Alignment | 3 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Trans-Activators/chemistry/*genetics/*metabolism | 2 | 11.0 |
DNA, Complementary | 2 | 0.0 |
Cytokines/*pharmacology | 2 | 0.0 |
Interleukin-7/pharmacology | 2 | 4.0 |
Cell Division/drug effects/genetics | 2 | 2.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Macrophage Colony-Stimulating Factor/*pharmacology | 2 | 5.0 |
Acute Disease | 2 | 0.0 |
DNA, Neoplasm/metabolism | 2 | 1.0 |
Prolactin/*pharmacology | 3 | 3.0 |
Models, Genetic | 2 | 0.0 |
Cell Nucleus/*enzymology | 2 | 5.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 2 | 1.0 |
Pulsatile Flow | 2 | 4.0 |
Molecular Weight | 2 | 0.0 |
Lymphocytes/*metabolism | 2 | 1.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Receptors, Somatotropin/genetics/*metabolism | 2 | 14.0 |
Transcription, Genetic/*physiology | 2 | 1.0 |
Organ Specificity | 2 | 0.0 |
*Transcription, Genetic | 3 | 0.0 |
Prolactin/metabolism | 2 | 3.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Trans-Activators/*genetics/metabolism | 2 | 1.0 |
*Cloning, Molecular | 2 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
